MoneyWorks4Me

The company witnessed a 9.48% growth in the revenue at Rs. 1464.49 millions for the quarter ended December 2023 as compared to Rs. 1337.66 millions during the year-ago period.A comparatively good net profit growth of 29.73% to Rs. 280.39 millions was reported for the quarter ended December 2023 compared to Rs. 216.14 millions of previous same quarter.OP of the company witnessed a marginal growth to 406.78 millions from 331.10 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1464.49 1337.66 9.48 4380.56 3978.49 10.11 5103.09 4720.79 8.10
Other Income 110.18 63.58 73.29 274.04 185.38 47.83 224.84 99.98 124.88
PBIDT 406.78 331.10 22.86 1089.26 911.10 19.55 1116.50 1054.68 5.86
Interest 1.55 3.31 -53.17 9.64 8.81 9.42 20.29 14.51 39.83
PBDT 405.23 327.79 23.62 1079.62 902.29 19.65 1096.21 1040.17 5.39
Depreciation 28.14 22.62 24.40 79.39 67.53 17.56 91.66 80.88 13.33
PBT 377.09 305.17 23.57 1000.23 834.76 19.82 1004.55 959.29 4.72
TAX 96.70 89.03 8.62 253.17 231.37 9.42 275.56 265.74 3.70
Deferred Tax 24.60 4.36 464.22 39.87 5.75 593.39 15.86 7.20 120.28
PAT 280.39 216.14 29.73 747.06 603.39 23.81 728.99 693.55 5.11
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 27.78 24.75 12.22 24.87 22.90 8.58 21.88 22.34 -2.07
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..